Clinical Trials
16 trialsNCT07628894 2026-06-05
Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy
City of Hope Medical Center
Phase 1 Not yet recruiting
NCT07581509 2026-05-14
Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma
Biocon Limited
Phase 1 Not yet recruiting
NCT07444606 2026-05-06
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
NCT07192471 2026-04-20
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Phase 1 Not yet recruiting
NCT07518043 2026-04-15
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
NCT07476326 2026-04-03
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Biocon Limited
Phase 1 Not yet recruiting
NCT07501117 2026-03-30
Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
Herlev Hospital
Phase 1 Not yet recruiting
NCT07475572 2026-03-16
A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
Alvotech Swiss AG
Phase 1 Not yet recruiting
NCT07320222 2026-01-06
CARE-Melanoma
McMaster University
Phase 1 Not yet recruiting
NCT07252661 2025-11-28
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
AccSalus Biosciences, Inc.
Phase 1 Not yet recruiting
NCT07183852 2025-09-19
GoTIL-01
Vastra Gotaland Region
Phase 1 Not yet recruiting
NCT07107178 2025-08-06
A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma
Biotroy Therapeutics
Phase 1 Not yet recruiting
NCT07100925 2025-08-03
A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
Ankyra Therapeutics, Inc
Phase 1 Not yet recruiting
NCT06385522 2025-07-08
A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System
Boston Immune Technologies and Therapeutics
Phase 1 Not yet recruiting
NCT06424626 2024-05-22
A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma
Peking University Cancer Hospital & Institute
Phase 1 Not yet recruiting
NCT05903937 2023-06-15
HAITILS-PHP
Vastra Gotaland Region
Phase 1 Not yet recruiting